Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian M Zeglis

Showing results (51-60 of 117) with videos related to

Pageof 12
Sort By:
Molecules (Basel, Switzerland)|May 21, 2020
<sup>89</sup>Zr-Labeled AR20.5: A MUC1-Targeting ImmunoPET ProbeKimberly Fung, Delphine Vivier, Outi Keinänen, et al.
Biomacromolecules|March 6, 2024
Tuning Supramolecular Chirality in Iodinated Amphiphilic Peptides Through Tripeptide Linker EditingDouglas S MacPherson, Dhwanit Dave, Salma Kassem, et al.
The Science of the Total Environment|August 16, 2023
Unraveling the in vivo fate of inhaled micro- and nanoplastics with PET imagingSamantha Delaney, Cindy Rodriguez, Samantha M Sarrett, et al.
Molecular Pharmaceutics|July 10, 2020
A Molecularly Targeted Intraoperative Near-Infrared Fluorescence Imaging Agent for High-Grade Serous Ovarian CancerKimberly Fung, Sai Kiran Sharma, Outi Keinänen, et al.
International Journal of Radiation Biology|June 20, 2025
Exploring Auger electron-emitting radionuclides for targeted DNA damage in mismatch repair-deficient cells: a theoretical study of <sup>99</sup>Rh- and <sup>123</sup>I-labeled metalloinsertorsAlexandre França Velo, Lukas Carter, Michael Bellamy, et al.
European Journal of Medicinal Chemistry|September 22, 2014
Synthesis and evaluation of (18)F-labeled ATP competitive inhibitors of topoisomerase II as probes for imaging topoisomerase II expressionPierre Daumar, Brian M Zeglis, Nicholas Ramos, et al.
Molecular Pharmaceutics|November 15, 2022
Leveraging a Dual Variable Domain Immunoglobulin to Create a Site-Specifically Modified RadioimmunoconjugateDouglas S MacPherson, Dobeen Hwang, Samantha M Sarrett, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 2015
Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation DosesJacob L Houghton, Brian M Zeglis, Dalya Abdel-Atti, et al.
Inorganic Chemistry|September 6, 2014
What a difference a carbon makes: H₄octapa vs H₄C3octapa, ligands for In-111 and Lu-177 radiochemistryEric W Price, Brian M Zeglis, Jacqueline F Cawthray, et al.
Molecular Pharmaceutics|April 25, 2020
Removal of Fc Glycans from [<sup>89</sup>Zr]Zr-DFO-Anti-CD8 Prevents Peripheral Depletion of CD8<sup>+</sup> T CellsJordan M White, Outi M Keinänen, Brendon E Cook, et al.
Pageof 12

Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
Molecules (Basel, Switzerland)|May 21, 2020
<sup>89</sup>Zr-Labeled AR20.5: A MUC1-Targeting ImmunoPET ProbeKimberly Fung, Delphine Vivier, Outi Keinänen, et al.
Biomacromolecules|March 6, 2024
Tuning Supramolecular Chirality in Iodinated Amphiphilic Peptides Through Tripeptide Linker EditingDouglas S MacPherson, Dhwanit Dave, Salma Kassem, et al.
The Science of the Total Environment|August 16, 2023
Unraveling the in vivo fate of inhaled micro- and nanoplastics with PET imagingSamantha Delaney, Cindy Rodriguez, Samantha M Sarrett, et al.
Molecular Pharmaceutics|July 10, 2020
A Molecularly Targeted Intraoperative Near-Infrared Fluorescence Imaging Agent for High-Grade Serous Ovarian CancerKimberly Fung, Sai Kiran Sharma, Outi Keinänen, et al.
International Journal of Radiation Biology|June 20, 2025
Exploring Auger electron-emitting radionuclides for targeted DNA damage in mismatch repair-deficient cells: a theoretical study of <sup>99</sup>Rh- and <sup>123</sup>I-labeled metalloinsertorsAlexandre França Velo, Lukas Carter, Michael Bellamy, et al.
European Journal of Medicinal Chemistry|September 22, 2014
Synthesis and evaluation of (18)F-labeled ATP competitive inhibitors of topoisomerase II as probes for imaging topoisomerase II expressionPierre Daumar, Brian M Zeglis, Nicholas Ramos, et al.
Molecular Pharmaceutics|November 15, 2022
Leveraging a Dual Variable Domain Immunoglobulin to Create a Site-Specifically Modified RadioimmunoconjugateDouglas S MacPherson, Dobeen Hwang, Samantha M Sarrett, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 2015
Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation DosesJacob L Houghton, Brian M Zeglis, Dalya Abdel-Atti, et al.
Inorganic Chemistry|September 6, 2014
What a difference a carbon makes: H₄octapa vs H₄C3octapa, ligands for In-111 and Lu-177 radiochemistryEric W Price, Brian M Zeglis, Jacqueline F Cawthray, et al.
Molecular Pharmaceutics|April 25, 2020
Removal of Fc Glycans from [<sup>89</sup>Zr]Zr-DFO-Anti-CD8 Prevents Peripheral Depletion of CD8<sup>+</sup> T CellsJordan M White, Outi M Keinänen, Brendon E Cook, et al.
Pageof 12